- Home
- FTHM vs ECOR Comparison
FTHM vs ECOR Comparison
Compare FTHM & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- ECOR
- Stock Information
- Founded
- FTHM 2010
- ECOR 2005
- Country
- FTHM United States
- ECOR United States
- Employees
- FTHM N/A
- ECOR N/A
- Industry
- FTHM Real Estate
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FTHM Finance
- ECOR Health Care
- Exchange
- FTHM Nasdaq
- ECOR Nasdaq
- Market Cap
- FTHM 38.3M
- ECOR 39.7M
- IPO Year
- FTHM 2020
- ECOR 2018
- Fundamental
- Price
- FTHM $1.30
- ECOR $5.24
- Analyst Decision
- FTHM Buy
- ECOR Strong Buy
- Analyst Count
- FTHM 1
- ECOR 2
- Target Price
- FTHM $2.50
- ECOR $25.50
- AVG Volume (30 Days)
- FTHM 150.0K
- ECOR 110.7K
- Earning Date
- FTHM 08-12-2025
- ECOR 08-06-2025
- Dividend Yield
- FTHM N/A
- ECOR N/A
- EPS Growth
- FTHM N/A
- ECOR N/A
- EPS
- FTHM N/A
- ECOR N/A
- Revenue
- FTHM $390,032,000.00
- ECOR $27,700,000.00
- Revenue This Year
- FTHM $32.40
- ECOR $23.21
- Revenue Next Year
- FTHM $18.04
- ECOR $44.10
- P/E Ratio
- FTHM N/A
- ECOR N/A
- Revenue Growth
- FTHM 19.16
- ECOR 30.16
- 52 Week Low
- FTHM $0.65
- ECOR $4.16
- 52 Week High
- FTHM $3.37
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- FTHM 50.06
- ECOR 38.40
- Support Level
- FTHM $1.05
- ECOR $4.16
- Resistance Level
- FTHM $1.50
- ECOR $7.40
- Average True Range (ATR)
- FTHM 0.14
- ECOR 0.53
- MACD
- FTHM 0.00
- ECOR -0.33
- Stochastic Oscillator
- FTHM 35.71
- ECOR 23.27
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.